Group 1 - The company Beijing Keri (002350) has recently announced that it is expected to win the bid for the first batch of framework bidding projects for distribution network equipment from Southern Power Grid Company for the year 2025 [1] - The anticipated bid amount is approximately 322 million yuan, which accounts for about 15.77% of the company's audited operating income for 2024 [1] - The execution of the project contract is expected to have a positive impact on the company's operating performance for the year 2025 and beyond, while not affecting the company's operational independence [1]

Summary of Key Points Core Viewpoint - Beijing Keri Group Co., Ltd. has approved a guarantee for its wholly-owned subsidiaries, Zhengzhou Keri Tongyuan Power Design Co., Ltd. and Sichuan Keri Ruiyi Power Engineering Co., Ltd., to support their financing needs, with a total guarantee amount not exceeding 141 million yuan, effective for one year from the board's approval date [1][5]. Guarantee Overview - The company plans to provide guarantees for bank comprehensive credit, joint bidding, issuance of letters of guarantee, project performance guarantees, and other daily operational financing for its subsidiaries [1][2]. - The total new guarantee amount is capped at 141 million yuan, which represents 8.35% of the company's most recent audited net assets [2][5]. Subsidiary Financials - **Zhengzhou Keri Tongyuan Power Design Co., Ltd.**: - Total assets as of June 30, 2025: 886.42 million yuan - Total liabilities: 584.49 million yuan - Net assets: 301.93 million yuan - Revenue for the first half of 2025: 81.53 million yuan - Net profit for the first half of 2025: -45.84 million yuan [3][5]. - **Sichuan Keri Ruiyi Power Engineering Co., Ltd.**: - Total assets as of June 30, 2025: 375.10 million yuan - Total liabilities: 256.63 million yuan - Net assets: 118.47 million yuan - Revenue for the first half of 2025: 13.69 million yuan - Net profit for the first half of 2025: 18.75 million yuan [3][5]. Board's Opinion - The board believes that providing guarantees for the subsidiaries is a necessary support for their operational development and that the financial risks are manageable. The subsidiaries are fully controlled by the company, allowing for adequate oversight of their operations [5][6]. Guarantee Management - The company has not provided counter-guarantees for the subsidiaries, and there are no overdue guarantee matters. The total external guarantees within the last 12 months amount to 58.96 million yuan, which is 3.49% of the company's most recent audited net assets [6].

关于为子公司提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 北京科锐集团股份有限公司（以下简称"公司"）于2025年7月1日召开第八 届董事会第十二次会议，审议通过了《关于为子公司提供担保的议案》，同意公 司为全资子公司郑州科锐同源电力设计有限公司（以下简称"同源电力"）、全 资二级子公司四川科锐锐意电力工程有限公司（以下简称"四川科锐"）的银行 综合授信、联合体投标、开具保函、项目履约担保或开展其他日常经营融资业务 提供担保，现将具体情况公告如下： 一、担保情况概述 1、根据公司及子公司业务发展需要，经全资子公司同源电力、全资二级子公 司四川科锐申请，公司计划为同源电力、四川科锐的银行综合授信、联合体投标、 开具保函、项目履约担保或开展其他日常经营融资业务提供担保，担保方式包括 但不限于连带责任担保、信用担保、抵押、质押等其他符合法律法规要求的担保。 本次新增担保额度总额不超过 14,100 万元，担保额度自本次董事会通过之日起有 效期 1 年。 2、根据《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规 范运作》《公司章程》和 ...

《关于为子公司提供担保的公告》详见公司指定信息披露媒体《中国证券报》 《证券时报》《证券日报》《上海证券报》和巨潮资讯网（http://www.cninfo.com.cn）。 第八届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 北京科锐集团股份有限公司（以下简称"公司"）第八届董事会第十二次会 议于 2025 年 7 月 1 日 8:30 以通讯方式召开，会议通知于 2025 年 6 月 30 日以邮件 及微信方式送达，本次会议为紧急会议，不受通知时限限制已在会前说明。本次 会议应到董事 9 名，实到董事 9 名。会议由公司董事长付小东先生主持。本次会 议符合《中华人民共和国公司法》《北京科锐集团股份有限公司章程》《董事会 议事规则》的规定，会议的召集、召开合法有效。本次董事会会议经审议通过如 下决议： 一、审议通过《关于为子公司提供担保的议案》 根据公司及子公司业务发展需要，经全资子公司郑州科锐同源电力设计有限 公司（以下简称"同源电力"）、全资二级子公司四川科锐锐意电力工程有限公 司（以下简称"四川科锐"）申请，同意公司为同源 ...

证券代码：002350 证券简称：北京科锐 公告编号：2025-053 根据公司中标比例及报价测算，上述项目预估中标金额合计约为 3.12 亿元， 占公司 2024 年经审计营业收入的 15.29%。上述项目合同的履行将对本公司 2025 年度及以后年度的经营业绩产生积极的影响，但不影响公司经营的独立性。 三、风险提示 北京科锐集团股份有限公司 关于项目中标的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 北京科锐集团股份有限公司（以下简称"公司"）于 2025 年 6 月 13 日、 2025 年 6 月 20 日在指定信息披露媒体《中国证券报》《证券时报》《证券日报》 《上海证券报》和巨潮资讯网（http://www.cninfo.com.cn）披露了《关于项目中标 的提示性公告》（公告编号：2025-050、2025-052），公司在"国家电网有限公 司 2025 年华北区域第一次联合采购 10kV 变压器协议库存招标采购项目""国 家电网有限公司 2025 年华中、川渝区域第一次联合采购 10kV 柱上变压器台成 套设备协议库存招标采购项目" ...

1 近日，国家电网有限公司在其电子商务平台（https://ecp.sgcc.com.cn）发布了 中标结果公告及中标候选人公示，北京科锐集团股份有限公司（以下简称"公司"） 为国家电网有限公司2025年西藏、西北区域第一次联合采购一二次融合成套柱上 断路器协议库存招标采购项目，国家电网有限公司2025年华东区域第一次联合采 购10kV变压器协议库存招标采购项目等多个项目的中标人或中标候选人，现将 公司中标及预中标情况公告如下： 证券代码：002350 证券简称：北京科锐 公告编号：2025-052 一、中标情况概述 北京科锐集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 根据以上项目公示或公告，本次公司中标及预中标金额合计约为15,436.49万 元，具体如下： 关于项目中标的提示性公告 | 招标项目名称 | | 招标编号 | 中标项目公示主要内 | 中标金 | | | --- | --- | --- | --- | --- | --- | | | | | 容 | 额（万 | 公示链接 | | 国家电网有限 | | | | 元） | | | ...

Core Viewpoint - Beijing Keri (002350) has recently won and pre-won multiple procurement projects from State Grid Corporation of China for 2025, with a total bid amount of approximately 154 million yuan, accounting for about 7.56% of the company's audited revenue for 2024 [1] Group 1 - The total bid amount for the projects is approximately 154 million yuan [1] - The projects include integrated column-mounted circuit breakers, ring network boxes, and complete sets of 10kV transformer equipment [1] - The execution of these contracts is expected to have a positive impact on the company's operating performance in 2025 and beyond [1]

Core Points - Beijing Keri Group Co., Ltd. has completed the registration of changes in its business scope and the filing of its Articles of Association [1][2] - The company held its 2024 annual general meeting on May 22, 2025, where it approved the proposal to change its business scope and amend its Articles of Association [1] - The company has obtained a new business license from the Haidian District Market Supervision Administration in Beijing [1] Business Scope Changes - The company’s new business scope includes power generation, transmission, and distribution services, as well as the installation, maintenance, and testing of electrical facilities [1][2] - The company is now involved in manufacturing and sales of various electrical and electronic equipment, including photovoltaic equipment, electric vehicle components, and industrial robots [1][2] - The company will also engage in research and development in areas such as carbon reduction technologies, energy efficiency, and artificial intelligence applications [1][2]

证券代码：002350 证券简称：北京科锐 公告编号：2025-051 北京科锐集团股份有限公司 关于变更经营范围暨完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 北京科锐集团股份有限公司（以下简称"公司"）于2025年5月22日召开2024 年度股东大会，审议通过《关于变更经营范围并修订<公司章程>的议案》，具体内 容详见公司于指定信息披露媒体《中国证券报》《证券时报》《证券日报》《上海 证券报》和巨潮资讯网（http：//www.cninfo.com.cn）披露的《关于变更经营范围并 修订<公司章程>的公告》（公告编号：2025-037）。 经营范围：许可项目：发电业务、输电业务、供（配）电业务；输电、供电、 受电电力设施的安装、维修和试验；检验检测服务；电气安装服务；电线、电缆制 造；道路机动车辆生产。（依法须经批准的项目，经相关部门批准后方可开展经营 活动，具体经营项目以相关部门批准文件或许可证件为准）一般项目：输配电及控 制设备制造；变压器、整流器和电感器制造；配电开关控制设备制造；配电开关控 制设备销售；输变配电监测控制设备 ...

Group 1 - Company GuoDeWei plans to repurchase shares with a total investment of between 100 million to 150 million yuan, with a maximum repurchase price of 53 yuan per share, expecting to buy back between 1.89 million to 2.83 million shares, accounting for 0.78% to 1.17% of total share capital [1] - Company Shuangliang Energy has won a bid for the Gansu Energy Chemical Qinyang 2×660MW coal power project, with a total bid amount of 237 million yuan, representing 1.82% of the company's projected revenue for 2024 [1] - Company China Pacific Insurance reported a total premium income of 227.17 billion yuan from its two subsidiaries in the first five months, with a year-on-year growth of 10.2% for its life insurance subsidiary and 0.5% for its property insurance subsidiary [1][2] Group 2 - Company LuKang Pharmaceutical has received a drug registration certificate for injectable Cefoperazone Sodium, a third-generation cephalosporin with broad-spectrum antibacterial properties [3] - Company 吉祥航空 reported a 4.97% year-on-year increase in passenger turnover in May, with a seat occupancy rate of 86.14%, up 3.70% year-on-year [4][5] - Company DuRui Pharmaceutical's subsidiary has also received a drug registration certificate for injectable Cefoperazone Sodium [6] Group 3 - Company KeLan Software announced that part of the shares held by its controlling shareholder will be auctioned, involving 5.09 million shares, accounting for 1.07% of the total share capital [7] - Company HuaCan Optoelectronics received a government subsidy of 87.84 million yuan, which is expected to positively impact the company's pre-tax profit for 2025 [8] - Company JinZhi Technology has won a bid for projects from the State Grid and China Resources New Energy, with a total bid amount of 84.41 million yuan [9] Group 4 - Company Vision China completed a capital increase for its subsidiary, raising 100 million yuan to accelerate its layout in the AI field [11] - Company Youa Co. received a profit distribution of 96.03 million yuan from its investment in Changsha Bank [13] - Company WanBangde's subsidiary obtained a patent for a deuterated compound, enhancing the chemical stability and reducing toxicity [16] Group 5 - Company DongCheng Pharmaceutical completed the enrollment of all 488 participants in the Phase III clinical trial for Fluorine-18 PSMA peptide injection, aimed at prostate cancer diagnosis [17] - Company China Merchants Expressway announced that its first phase of medium-term notes for 2024 will pay interest on July 2, 2025, with a total issuance of 2.5 billion yuan and an interest rate of 2.35% [18] - Company JinPu Titanium's subsidiary has temporarily suspended production for maintenance due to falling product prices and high production costs [20] Group 6 - Company BeiLu Pharmaceutical received a marketing authorization for Iodinated Contrast Injection in Hungary, marking another approval in the EU [22] - Company LiXing Co. obtained an overseas investment certificate for its wholly-owned subsidiary in Singapore, with a total investment of 2.16 million yuan [24] - Company LangKun Technology won a garbage collection service project with a bid amount of 21.57 million yuan [26] Group 7 - Company KeRui International plans to transfer 55% of its subsidiary Tianjin ZhiRui's equity for 41.96 million yuan [28] - Company Nanjing JuLong intends to invest 130 million yuan to build a production project for special materials with an annual output of 40,000 tons [30] - Company NanShan Intelligent plans to use up to 50 million yuan of idle funds for cash management in safe and liquid financial products [32] Group 8 - Company GuangLian Aviation completed the business change registration for its subsidiary, involving the introduction of strategic investors [34] - Company XiaoFang Pharmaceutical signed a cooperation agreement to develop a new drug for hair loss treatment [36] - Company GuiZhou SanLi plans to sign a 150 million yuan technology transfer and development contract with Guangdong Pharmaceutical University [38] Group 9 - Company ST SiLong's subsidiary received a drug registration certificate for Famotidine injection, used for treating upper gastrointestinal bleeding [52] - Company ZhongKe Information's executive plans to reduce holdings of up to 180,000 shares, accounting for 0.06% of total share capital [53] - Company KeLun Pharmaceutical's injectable Cefoperazone Sodium/Chloride Sodium injection received drug registration approval [54] Group 10 - Company LuXin Investment plans to transfer 10.06% of its stake in LuXin HuiJin for 203 million yuan, aiming to focus on its main business [56] - Company Western Gold plans to acquire 100% of Xinjiang MeiSheng for 1.655 billion yuan [58] - Company JinTou City Development intends to swap assets worth 5.862 billion yuan, changing its main business to urban centralized heating [60]